Jagsonpal Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Sep ' 24	Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21

Sales

136.13

117.98

121.12

106.61

119.49

Operating profit

26.52

17.00

20.08

6.24

19.56

Interest

0.44

0.37

0.04

0.12

0.17

Gross profit

29.18

20.90

21.48

8.35

20.49

EPS (Rs)

2.54

2.28

2.04

0.83

2.16

Other income

3.10

4.27

1.43

2.23

1.11

Stock adjustment

-2.99

2.38

4.66

2.51

3.10

Raw material

9.59

12.43

18.77

17.46

22.96

Power and fuel

-

-

-

-

-

Employee expenses

31.41

25.41

29.87

29.21

28.47

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

71.60

60.77

47.74

51.19

45.40

Provisions made

-

-

-

-

-

Depreciation

3.41

0.85

0.40

1.02

0.51

Taxation

5.69

5.10

4.29

1.91

5.83

Net profit / loss

16.79

14.95

13.33

5.43

14.16

Extra ordinary item

-3.29

-

-3.46

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

13.24

13.10

13.10

13.10

13.10

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

19.48

14.41

16.58

5.85

16.37

GPM (%)

20.96

17.10

17.52

7.67

16.99

NPM (%)

12.06

12.23

10.88

4.99

11.74